Abstract:Gold nanostructures with promising applications in biomedical field have attracted great attention. However, some fundamental questions other than the development of novel applications should be elucidated before they can actually serve as biomedicines in the clinic. Bio-safety is one of the most important issues. Since numerous modifications (e.g., surface coating and composites) have been designed on gold nanoparticles (GNPs) to extend their application, there would be hundreds of GNPs synthesized in the lab although the prototypes of GNPs (i.e., cluster, shell, rod, sphere, cage, and star) are rather limited. Thus, in the present work we aim to conduct our experiments only on the most basic types of GNPs--including gold nanocluster (GNC), gold nanorod (GNR) and gold nanosphere (GNS), to investigate their biodistribution and toxicities in vivo, in the hope of revealing some basic rules which could be further extended to other complicated situations. Bovine serum albumin (BSA) was coated at the surface to increase their plasma stability and of the same BSA coating would help to compare the fate and behaviors of various GNPs in vivo. After intravenous administration of different GNPs with an equal content of gold element at 0.5 mg/kg in mice, samples were harvested at a series of time points. Biodistribution was compared among different GNPs and the process of accumulation-retention-clearance of each kind of GNP was also observed through quantification analysis by inductively coupled plasma-mass spectrometry (ICP-MS). The results showed, with the same BSA coating at the surface and similar negative charge, size rather than shape was dominating the in vivo fate of GNPs. Even between GNC and hydrolyzed GNC with their size at 7.1 and 3.2 nm, huge difference in the kidney accumulation was observed. Totally, GNR and GNS in relative large size preferred to accumulate in liver and spleen whereas GNC in relative small size tended to accumulate in liver and kidney. GNPs resided in liver were hardly cleared out of body till 28 d whereas their accumulation in kidney was almost entirely eliminated with prolonged time, although not as rapid as reported in previous work. In vivo toxicities evaluated by pathology observation and blood biochemical analysis also revealed slight liver and kidney damage, basically associated with the biodistribution pattern of GNPs.

Accumulation and toxicity of biologically produced gold nanoparticles in different types of specialized mammalian cells

Long-Term Accumulation, Biological Effects and Toxicity of BSA-Coated Gold Nanoparticles in the Mouse Liver, Spleen, and Kidneys

Bioproduced Nanoparticles Deliver Multiple Cargoes via Targeted Tumor Therapy In Vivo

Effect of Surface Chemistry Modification of Functional Gold Nanoparticles on the Drug Accumulation of Cancer Cells

Size- and surface chemistry-dependent pharmacokinetics and tumor accumulation of engineered gold nanoparticles after intravenous administration.

Effect of Gold (au) Nanoparticles Modified by Surface Chemistry on the Proliferation and Migration of Hepatocellular Carcinoma Cells in Vitro

Toxicity of gold nanoparticles (AuNPs): A review

Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles

The enhancement effect of gold nanoparticles in drug delivery and as biomarkers of drug-resistant cancer cells.

Cytotoxicity of Bsa-Stabilized Gold Nanoclusters: in Vitro and in Vivo Study

Surface and Size Effects on Cell Interaction of Gold Nanoparticles with Both Phagocytic and Nonphagocytic Cells

Anticancer potential of gold nanoparticles (AuNPs) using a battery of in vitro tests

Multiparametric Assessment of Gold Nanoparticle Cytotoxicity in Cancerous and Healthy Cells: The Role of Size, Shape, and Surface Chemistry

Anticancer Effects of Gold Nanoparticles by Inducing Apoptosis in Bladder Cancer 5637 Cells

Interaction of Gold Nanoparticles with Proteins and Cells

The Systematic Evaluation of Size-Dependent Toxicity and Multi-Time Biodistribution of Gold Nanoparticles.

Quantitative Biokinetics and Systemic Translocation of Various Gold Nanostructures Are Highly Dependent on Their Size and Shape.

Toxicologic Effects of Gold Nanoparticles in Vivo by Different Administration Routes

Gold Nanoparticles Inhibit Tumor Growth Via Targeting the Warburg Effect in a C-Myc-dependent Way.

Multicomponent delivery system based on biologically produced gold nanoparticles for targeted therapy of breast cancer in vivo

Beyond gold nanoparticles cytotoxicity: potential to impair metastasis hallmarks